Among them, dystroglycanopathies represent a significant subgroup, which is characterized by hypoglycosylation of α-dystroglycan (DG; OMIM 128239) [1]. This evidence concerns the gene DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.